Skip to main content
Log in

Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas

  • Short Communication
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant cancer syndromes worldwide. Individuals with NF1 have a wide variety of clinical features including a strongly increased risk for pediatric brain tumors. The etiology of pediatric brain tumor development in NF1 is largely unknown. Recent studies have highlighted the contribution of parent-of-origin effects to tumorigenesis in sporadic cancers and cancer predisposition syndromes; however, there is limited data on this effect for cancers arising in NF1. To increase our understanding of brain tumor development in NF1, we conducted a multi-center retrospective chart review of 240 individuals with familial NF1 who were diagnosed with a pediatric brain tumor (optic pathway glioma; OPG) to determine whether a parent-of-origin effect exists overall or by the patient’s sex. Overall, 50 % of individuals with familial NF1 and an OPG inherited the NF1 gene from their mother. Similarly, by sex, both males and females were as likely to inherit the NF1 gene from their mother as from their father, with 52 % and 48 % of females and males with OPGs inheriting the NF1 gene from their mother. In conclusion, in contrast to findings from other studies of sporadic cancers and cancer predisposition syndromes, our results indicate no parent-of-origin effect overall or by patient sex for OPGs in NF1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from €37.37 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price includes VAT (Netherlands)

Instant access to the full article PDF.

References

  1. Lynch TM, Gutmann DH (2002) Neurofibromatosis 1. Neurol Clin 20(3):841–865

    Article  PubMed  Google Scholar 

  2. Littler M, Morton NE (1990) Segregation analysis of peripheral neurofibromatosis (NF1). J Med Genet 27(5):307–310

    Article  PubMed  CAS  Google Scholar 

  3. Dalla Via P, Opocher E, Pinello ML et al (2007) Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol 9(4):430–437

    Article  PubMed  Google Scholar 

  4. Josefson J, Listernick R, Fangusaro JR, Charrow J, Habiby R (2011) Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors. J Pediatr 158(3):433–436

    Article  PubMed  CAS  Google Scholar 

  5. van Vliet CM, Dowty JG, van Vliet JL et al (2011) Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes. Hum Mutat 32(2):207–212

    Article  PubMed  Google Scholar 

  6. Kong A, Steinthorsdottir V, Masson G et al (2009) Parental origin of sequence variants associated with complex diseases. Nature 462(7275):868–874

    Article  PubMed  CAS  Google Scholar 

  7. Yeap PM, Tobias ES, Mavraki E et al (2011) Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect. J Clin Endocrinol Metab 96(12):E2009–E2013

    Article  PubMed  CAS  Google Scholar 

  8. Muller U (2011) Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC). Neurogenetics 12(3):175–181

    Article  PubMed  Google Scholar 

  9. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP (1984) von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology 91(8):929–935

    PubMed  CAS  Google Scholar 

  10. Miller M, Hall JG (1978) Possible maternal effect on severity of neurofibromatosis. Lancet 2(8099):1071–1073

    Article  PubMed  CAS  Google Scholar 

  11. Riccardi VM, Wald JS (1987) Discounting an adverse maternal effect on severity of neurofibromatosis. Pediatrics 79(3):386–393

    PubMed  CAS  Google Scholar 

  12. Szudek J, Joe H, Friedman JM (2002) Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Genet Epidemiol 23(2):150–164

    Article  PubMed  CAS  Google Scholar 

  13. Reilly KM, Tuskan RG, Christy E et al (2004) Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci USA 101(35):13008–13013

    Article  PubMed  CAS  Google Scholar 

  14. Tuskan RG, Tsang S, Sun Z et al (2008) Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels. Epigenetics 3(1):43–50

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the funding by NCI/NIH RO1CA118389 to Dr. Rubin. We would also like to thank Elena Mamontov for her assistance with assembling clinical data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. J. Johnson.

Additional information

J. B. Rubin and D. H. Gutmann have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, K.J., Fisher, M.J., Listernick, R.L. et al. Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas. Familial Cancer 11, 653–656 (2012). https://doi.org/10.1007/s10689-012-9549-z

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1007/s10689-012-9549-z

Keywords

Profiles

  1. D. H. Gutmann